Second Amendment to Non-Exclusive License Agreement between Bio-Rad Laboratories, Inc. and Biodesix, Inc.
Bio-Rad Laboratories, Inc. and Biodesix, Inc. have agreed to extend their existing Non-Exclusive License Agreement until August 1, 2026. This amendment also updates the contact information for Bio-Rad. All other terms of the original agreement remain unchanged. The amendment is effective as of May 22, 2024, and must be signed by both parties to be valid.
Exhibit 10.1
SECOND AMENDMENT TO THE NON-EXCLUSIVE LICENSE AGREEMENT
This second amendment (“Amendment”) is effective May 22, 2024 (“Amendment Effective Date”), and is made pursuant to the Non-Exclusive License Agreement dated August 1, 2019, as amended (“Agreement”) by and between BIO-RAD LABORATORIES, INC., having an address at 1000 Alfred Nobel Drive, Hercules, California 94547 (“Bio-Rad”) and BIODESIX, INC., a Delaware corporation, with a principal business address at 2970 Wilderness Place, Suite 100 Boulder, CO 80301, USA (“Biodesix”) (individually, a “Party”; collectively, the “Parties”).
Whereas, the Parties have agreed to extend the term of the Agreement,
Now Therefore, for good and valuable consideration, the Parties agree as follows:
Bio-Rad Laboratories, Inc. 2000 Alfred Nobel Drive Hercules, CA, USA 94547 Attn:
Email:
In Witness Hereof, the Parties executed this Amendment as of the Amendment Effective Date.
Bio-Rad Laboratories, Inc.
| /s/ STEVE KULISCH |
By: | STEVE KULISCH |
Its: | VP, PRODUCT MANAGEMENT |
Biodesix, Inc.
| /s/ ROBIN HARPER COWIE |
By: | ROBIN HARPER COWIE |
Its: | CHIEF FINANCIAL OFFICER |